Onito, Marcedita G.

HRN: 21-81-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFUROXIME 500MG (TAB)
08/17/2022
08/25/2022
PO
500mg
Q12
Septic Incomplete Abortion
Waiting Final Action 

Indication:  ProphylaxisEmpirical De-escalation    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: